Neurological Surgery

Publications

Found 32 results

Author Title [ Type

] Year

Filters: Author is Kaplitt, Michael G [Clear All Filters]

Journal Article

Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D et al.. 2007. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet. 369(9579):2097-105.

Kaplitt MG, Krishna V, Eisenberg HM, W Elias J, Ghanouni P, Baltuch GH, Rezai A, Halpern CH, Dalm B, Fishman PS et al.. 2024. Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor: An Open-Label Clinical Trial. JAMA Neurol.

Stavarache MA, Petersen N, Jurgens EM, Milstein ER, Rosenfeld ZB, Ballon DJ, Kaplitt MG. 2018. Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound. J Neurosurg. 130(3):989-998.

Alexander B, Warner-Schmidt J, Eriksson T, Tamminga C, Arango-Lievano M, Ghose S, Vernov M, Stavarache M, Musatov S, Flajolet M et al.. 2010. Reversal of depressed behaviors in mice by p11 gene therapy in the nucleus accumbens. Sci Transl Med. 2(54):54ra76.

Weidman EK, Kaplitt MG, Strybing K, J Chazen L. 2019. Repeat magnetic resonance imaging-guided focused ultrasound thalamotomy for recurrent essential tremor: case report and review of MRI findings.. J Neurosurg. :1-6.

Weidman EK, Kaplitt MG, Strybing K, J Chazen L. 2019. Repeat magnetic resonance imaging-guided focused ultrasound thalamotomy for recurrent essential tremor: case report and review of MRI findings.. J Neurosurg. :1-6.

Schintu N, Zhang X, Alvarsson A, Marongiu R, Kaplitt MG, Greengard P, Svenningsson P. 2016. p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism.. Proc Natl Acad Sci U S A. 113(5):1429-34.

Virk MS, Sagi Y, Medrihan L, Leung J, Kaplitt MG, Greengard P. 2016. Opposing roles for serotonin in cholinergic neurons of the ventral and dorsal striatum.. Proc Natl Acad Sci U S A. 113(3):734-9.

Takahashi A, Aleyasin H, Stavarache MA, Li L, Cathomas F, Parise LF, Lin H-Y, C Burnett J, Aubry A, Flanigan ME et al.. 2021. Neuromodulatory effect of interleukin 1β in the dorsal raphe nucleus on individual differences in aggression.. Mol Psychiatry.

Fishman PS, W Elias J, Ghanouni P, Gwinn R, Lipsman N, Schwartz M, Chang JW, Taira T, Krishna V, Rezai A et al.. 2018. Neurological adverse event profile of magnetic resonance imaging-guided focused ultrasound thalamotomy for essential tremor.. Mov Disord. 33(5):843-847.

Xie L, Cen L-P, Li Y, Gilbert H-Y, Strelko O, Berlinicke C, Stavarache MA, Ma M, Wang Y, Cui Q et al.. 2022. Monocyte-derived SDF1 supports optic nerve regeneration and alters retinal ganglion cells' response to Pten deletion.. Proc Natl Acad Sci U S A. 119(15):e2113751119.

Parker WE, Weidman EK, J Chazen L, Niogi SN, Uribe-Cardenas R, Kaplitt MG, Hoffman CE. 2019. Magnetic resonance-guided focused ultrasound for ablation of mesial temporal epilepsy circuits: modeling and theoretical feasibility of a novel noninvasive approach.. J Neurosurg. :1-8.

Niethammer M, Tang CC, LeWitt PA, Rezai AR, Leehey MA, Ojemann SG, Flaherty AW, Eskandar EN, Kostyk SK, Sarkar A et al.. 2017. Long-term follow-up of a randomized AAV2- gene therapy trial for Parkinson's disease.. JCI Insight. 2(7):e90133.

Stavarache MA, J Chazen L, Kaplitt MG. 2021. Innovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders.. World Neurosurg. 145:581-589.

Ebani EJ, Kaplitt MG, Wang Y, Nguyen TD, Askin G, J Chazen L. 2020. Improved targeting of the globus pallidus interna using quantitative susceptibility mapping prior to MR-guided focused ultrasound ablation in Parkinson's disease.. Clin Imaging. 68:94-98.

D'Souza M, Chen KS, Rosenberg J, W Elias J, Eisenberg HM, Gwinn R, Taira T, Chang JWoo, Lipsman N, Krishna V et al.. 2019. Impact of skull density ratio on efficacy and safety of magnetic resonance-guided focused ultrasound treatment of essential tremor.. J Neurosurg. 132(5):1392-1397.

Kaplitt MG. 2019. Gene-targeting approaches for movement disorders: recent advances.. Curr Opin Neurol. 32(4):566-570.

Niethammer M, Tang CC, Vo A, Nguyen N, Spetsieris P, Dhawan V, Ma Y, Small M, Feigin A, During MJ et al.. 2018. Gene therapy reduces Parkinson's disease symptoms by reorganizing functional brain connectivity.. Sci Transl Med. 10(469)

Gelfand Y, Kaplitt MG. 2013. Gene therapy for psychiatric disorders.. World Neurosurg. 80(3-4):S32.e11-8.

Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, M Cenci A, Svenningsson P, Greengard P, Kaplitt MG. 2016. Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice.. Proc Natl Acad Sci U S A. 113(5):1423-8.

Stavarache MA, J Chazen L, Kaplitt MG. 2021. Foundations of Magnetic Resonance-Guided Focused Ultrasonography.. World Neurosurg. 145:567-573.

Bae J, Qayyum S, Zhang J, Das A, Reyes I, Aronowitz E, Stavarache MA, Kaplitt MG, Masurkar A, Kim SGene. 2024. Feasibility of measuring blood-brain barrier permeability using ultra-short echo time radial magnetic resonance imaging.. J Neuroimaging.

Amin-Hanjani S, Bambakidis NC, Barker FG, Carter BS, Cockroft KM, Du R, Fraser JF, Hamilton MG, Huang J, Jane JA et al.. 2020. Editorial. COVID-19 and neurosurgical practice: an interim report.. J Neurosurg. :1-2.

González-Rodríguez P, Zampese E, Stout KA, Guzman JN, Ilijic E, Yang B, Tkatch T, Stavarache MA, Wokosin DL, Gao L et al.. 2021. Disruption of mitochondrial complex I induces progressive parkinsonism.. Nature.

J Chazen L, Stradford T, Kaplitt MG. 2019. Cranial MR-guided Focused Ultrasound for Essential Tremor : Technical Considerations and Image Guidance.. Clin Neuroradiol. 29(2):351-357.